Evidence map›Paper›PMID 40958741›Full record

ArticleActa crystallographica. Section C, Structural chemistry2025

A good-practice guide to solving and refining molecular organic crystal structures from laboratory powder X-ray diffraction data.

Elena Kabova, Margarita Mersiyanova, Kenneth Shankland, Norman Shankland, Mark Spillman

Abstract read
In one paragraph

Article in Acta crystallographica. Section C, Structural chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elena KabovaSchool of Pharmacy, University of Reading, Reading, United Kingdom.ORCID 0000-0002-5812-735X
Margarita MersiyanovaSchool of Pharmacy, University of Reading, Reading, United Kingdom.
Kenneth ShanklandSchool of Pharmacy, University of Reading, Reading, United Kingdom.ORCID 0000-0001-6566-0155
Norman ShanklandIndependent Researcher, United Kingdom.
Mark SpillmanSchool of Pharmacy, University of Reading, Reading, United Kingdom.

Funding

Engineering and Physical Sciences Research Council EP/P020194/1Engineering and Physical Sciences Research Council EP/T022213/1Engineering and Physical Sciences Research Council EP/W032260/1
6 · The paper itself

Abstract

This article focuses on a specific real-space methodology for solving and refining molecular organic crystal structures, developed by the authors and collaborators. It outlines a practical route from polycrystalline samples to refined crystal structures, emphasizing efficient global optimization by DASH and the robust refinement capabilities of TOPAS. The approach prioritizes laboratory-to-laboratory reproducibility via a standardized workflow that addresses key challenges in molecular organic crystal structure determination.

Indexed as

crystal structure solution and refinementDASHgood practicemolecular crystal structurespowder X-ray diffractionTOPAS-Academic

Identifiers

PMID40958741
PMCPMC12497095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.